Posterior chamber phakic intraocular lens implantation after laser in situ keratomileusis.
Kazutaka KamiyaKimiya ShimizuAkihito IgarashiYoshihiro KitazawaTakashi KojimaTomoaki NakamuraKazuo IchikawaSachiko FukuokaKahoko Fujimotonull nullPublished in: Eye and vision (London, England) (2022)
Our multicenter study confirmed that the EVO-ICL provided good outcomes in safety, efficacy, predictability, and stability, even in post-LASIK eyes. Therefore, EVO-ICL implantation may be a viable surgical option, even for correcting residual refractive errors after LASIK. Trial registration University Hospital Medical Information Network Clinical Trial Registry (000045295).